Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-36905

Single-particle
3.41 Å
EMD-36905
3D View Gallery
Deposition: 21/07/2023
Map released: 27/12/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-36905
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8k5g summary report (pdf.gz) Map and 8k5g FULL report (pdf.gz)
EMICSS annotations (xml)

SARS-CoV-2 BA.1 RBD with UT28-RD

EMD-36905

Single-particle
3.41 Å
EMD-36905
3D View Gallery
Deposition: 21/07/2023
Map released: 27/12/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 BA.1 spike protein with UT28K-RD complex
Fitted models: 8k5g

Deposition Authors: Chen L, Kita S, Anraku Y , Maenaka K
Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.
Ozawa T , Ikeda Y, Chen L, Suzuki R, Hoshino A, Noguchi A, Kita S, Anraku Y , Igarashi E, Saga Y, Inasaki N, Taminishi S, Sasaki J, Kirita Y, Fukuhara H, Maenaka K, Hashiguchi T, Fukuhara T, Hirabayashi K, Tani H, Kishi H, Niimi H
(2024) Structure , 32 , 263 - 272.e7
PUBMED: 38228146
DOI: doi:10.1016/j.str.2023.12.013
ISSN: 0969-2126
ASTM: STRUE6